Your browser doesn't support javascript.
Respiratory syncytial virus after the SARS-CoV-2 pandemic - what next?
Mosscrop, Lucy G; Williams, Thomas C; Tregoning, John S.
  • Mosscrop LG; Department of Infectious Disease, Imperial College London, London, UK.
  • Williams TC; Child Life and Health, University of Edinburgh, Edinburgh, UK.
  • Tregoning JS; Department of Infectious Disease, Imperial College London, London, UK. john.tregoning@imperial.ac.uk.
Nat Rev Immunol ; 22(10): 589-590, 2022 10.
Article in English | MEDLINE | ID: covidwho-1931418

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Syncytial Virus, Human / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: S41577-022-00764-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Syncytial Virus, Human / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: S41577-022-00764-7